Advanced biologics technology platform for next-gen immunotherapies
Total raised: $71.5M
Investors 2
| Date | Name | Website |
| - | Vida Ventu... | vidaventur... |
| - | The Column... | thecolumng... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.10.2020 | Series B | $71.5M | Nextech In... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 18.01.2022 | A2 Bio to Present at ASCO-GI 2022 on Use of Next Generation ... | NGS assay by Tempus is able to identify GI cancer patients with clonal Human Leukocyte Antigen Loss ... | venturebea... |
| - | A2 Biotherapeutics | “Home | A2 Bio Therapeutics” | fastfounde... |